2025 Academy

KSMO 2025
Seoul, Korea Park Sehhoon Seoul, Korea Park Sehhoon

KSMO 2025

AI-powered Cell Type Quantification from Pre-neoadjuvant Slides as a Biomarker of Clinical Outcomes in Resectable Non-small Cell Lung Cancer.

Yoojin Kim

Read More